Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on (S) Duloxetine Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102191293A reveals a novel immobilized yeast method for high-purity duloxetine intermediates, offering significant cost reduction in API manufacturing and scalable supply chain solutions.
Patent CN104152506B reveals a crude enzyme system for high-purity pharmaceutical intermediates. This method offers significant supply chain and cost advantages for global buyers.
Novel Ru-catalyzed route for (S)-duloxetine intermediate offers high ee and yield without nitrogen protection, reducing manufacturing costs.